Health Care & Life Sciences » Pharmaceuticals | Jagsonpal Pharmaceuticals Ltd.

Jagsonpal Pharmaceuticals Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
1,439
1,382
1,435
1,442
1,265
1,668
Cost of Goods Sold (COGS) incl. D&A
1,092
1,063
1,035
1,048
1,033
1,205
Gross Income
347
319
399
394
232
464
SG&A Expense
266
258
312
351
346
380
EBIT
79
60
87
41
114
83
Non Operating Income/Expense
-
1
6
128
5
14
Interest Expense
54
45
53
26
7
7
Pretax Income
25
17
41
144
116
90
Income Tax
4
5
8
25
1
18
Consolidated Net Income
21
12
33
119
116
72
Net Income
21
12
33
119
116
72
Net Income After Extraordinaries
21
12
33
119
116
72
Net Income Available to Common
21
12
33
119
116
72
EPS (Basic)
0.81
0.45
1.24
4.53
4.41
2.75
Basic Shares Outstanding
26
26
26
26
-
-
EPS (Diluted)
0.81
0.45
1.24
4.53
-
-
Diluted Shares Outstanding
26
26
26
26
-
-
EBITDA
107
87
118
61
111
93
Other Operating Expense
-
3
1
2
-
-
Non-Operating Interest Income
-
1
1
1
-
-

About Jagsonpal Pharmaceuticals

View Profile
Address
T-210 J, Shahpur Jat
New Delhi Delhi 110049
India
Employees -
Website http://www.jagsonpal.com
Updated 07/08/2019
Jagsonpal Pharmaceuticals Ltd. is a pharmaceutical company, which engages in the development and manufacture of intermediate drugs and pharmaceutical formulations. Its products include capsule, tablet, ampoule, and syrup. The company was founded by Jagmohan Singh Kochhar in 1964 and is headquartered in New Delhi, India.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.